Tighe Reardon's Insider Trades & SAST Disclosures

Tighe Reardon's most recent trade in Janux Therapeutics Inc was a trade of 691,525 Common Stock done at an average price of $54.8 . Disclosure was reported to the exchange on June 3, 2024.

Share

Note

This is a custom search result for pattern Tighe Reardon.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Janux Therapeutics Inc 52 week low	Tighe Reardon	Acting Chief Financial Officer		03 Jun 2024	691,525	3,340,018	-	54.8	37,860,994	Common Stock
Janux Therapeutics Inc 52 week low	Tighe Reardon	Acting Chief Financial Officer		03 Jun 2024	131,196	633,673	-	54.8	7,182,981	Common Stock
Janux Therapeutics Inc 52 week low	Tighe Reardon	Acting Chief Financial Officer, Ten Percent Owner		02 Jan 2024	157,000	157,000	-		-	Stock Option (right to buy)
Janux Therapeutics Inc 52 week low	Tighe Reardon	Acting Chief Financial Officer, Ten Percent Owner		13 Nov 2023	849,854	849,854	-	5.9	4,988,643	Common Stock
Janux Therapeutics Inc 52 week low	Tighe Reardon	Acting Chief Financial Officer, Ten Percent Owner		03 Jan 2023	110,000	110,000	-		-	Stock Option (right to buy)
Janux Therapeutics Inc 52 week low	Tighe Reardon	Acting Chief Financial Officer, Ten Percent Owner		03 Jan 2022	116,750	116,750	-		-	Stock Option (right to buy)
Janux Therapeutics Inc 52 week low	Tighe Reardon	Acting Chief Financial Officer, Ten Percent Owner		15 Jun 2021	2,696,843	2,696,843	-		-	Common Stock
Janux Therapeutics Inc 52 week low	Tighe Reardon	Acting Chief Financial Officer, Ten Percent Owner		15 Jun 2021	2,105,264	0	-		-	Series A Convertible Preferred Stock
Janux Therapeutics Inc 52 week low	Tighe Reardon	Acting Chief Financial Officer, Ten Percent Owner		15 Jun 2021	1,153,238	3,850,081	-		-	Common Stock
Janux Therapeutics Inc 52 week low	Tighe Reardon	Acting Chief Financial Officer, Ten Percent Owner		15 Jun 2021	900,264	0	-		-	Series B Convertible Preferred Stock
Janux Therapeutics Inc 52 week low	Tighe Reardon	Acting Chief Financial Officer, Ten Percent Owner		15 Jun 2021	629,411	4,479,492	-	17	10,699,987	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades